From the very beginning, Robert "Bob" Preti had a penchant for inspiring others. He
began in the classroom, teaching as an elementary and secondary teacher, then as a
professor at New York City area colleges. Bob received a Bachelor of Science degree
in biology from Fordham University, and a Master of Science degree and Doctorate,
both in biology, from New York University. He held several roles with the New York
Blood Center from 1990 to 1997, including tissue bank director, director of hematopoietic
stem cell processing, scientific director and associate investigator. From 1996 to
1999, Bob was the director of hematopoietic stem cell processing and applied research
at Hackensack University Medical Center in Hackensack, N.J. He also worked as a research
scientist for Advanced Tissue Sciences, where his work lead to the Dermagraft product
currently marketed by Organogenesis. This interesting career path led Bob to co-founding
a contract development and manufacturing organization, the highly innovative PCT Cell
Therapy Services, in 1999, which he has led for its now twentyyear history. After
PCT's acquisition by Hitachi Chemical in 2017, Bob's role expanded as he became responsible
for development, management and oversight of the global business operations of Hitachi
Chemical's regenerative medicine business unit as its General Manager. In addition,
he has served in a leadership capacity for many professional organizations, including
treasurer and founding member of the International Society for Cellular Therapy (ISCT).
He recently completed a five-year term as a director for AABB as well as a two-and-a-half-year
term as Chairman for the Alliance for Regenerative Medicine, where he previously served
as Vice Chairman and co-chaired the Standards and Technology Committee. He has published
and presented extensively on a variety of topics related to cellular therapies.
To read this article in full you will need to make a payment
© 2019 Published by Elsevier B.V. on behalf of International Society for Cell and Gene Therapy.